| abstract |
Sphingosine 1-phosphate analogs are provided that are effective against one or more S1P receptors (particularly the S1P 1 receptor type) and are selective agonists. The disclosed compounds include compounds having not only the optional phosphate component, but also hydrolysis-resistant phosphate surrogates (eg, phosphonates, alpha-substituted phosphonates, and phosphothionates). |